Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628655/
https://www.ncbi.nlm.nih.gov/pubmed/36339328
http://dx.doi.org/10.1136/bmjno-2022-000285corr1
_version_ 1784823233905688576
collection PubMed
description
format Online
Article
Text
id pubmed-9628655
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96286552022-11-03 Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor BMJ Neurol Open Correction BMJ Publishing Group 2022-10-31 /pmc/articles/PMC9628655/ /pubmed/36339328 http://dx.doi.org/10.1136/bmjno-2022-000285corr1 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor
title Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor
title_full Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor
title_fullStr Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor
title_full_unstemmed Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor
title_short Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor
title_sort correction: refractory mycobacterium genavense infection secondary to thymoma-associated endogenous il-12 inhibitor
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628655/
https://www.ncbi.nlm.nih.gov/pubmed/36339328
http://dx.doi.org/10.1136/bmjno-2022-000285corr1

Ejemplares similares